Spread the love

How does rapamycin, a caloric restriction mimetic, inhibit mTOR signaling?

One of the key mechanisms through which rapamycin exerts its effects is by inhibiting the mammalian target of rapamycin (mTOR) signaling pathway. mTOR is a highly conserved protein kinase that plays a central role in regulating cellular processes such as growth, metabolism, and autophagy.

See also How do changes in life expectancy affect retirement funding?

Rapamycin binds to a protein called FK506-binding protein 12 (FKBP12), forming a complex that inhibits the activity of mTOR complex 1 (mTORC1). This inhibition leads to a downregulation of mTORC1-dependent signaling pathways, including the phosphorylation of downstream targets such as p70S6 kinase and 4E-BP1.

By inhibiting mTOR signaling, rapamycin promotes autophagy, a cellular process that involves the degradation and recycling of damaged or unnecessary cellular components. Autophagy has been linked to various health benefits, including improved cellular function, reduced accumulation of toxic proteins, and increased lifespan.

Furthermore, rapamycin-mediated inhibition of mTOR signaling also affects other cellular processes, such as protein synthesis and cell growth. This can have profound effects on cellular metabolism and energy balance, which are important factors in the regulation of lifespan and healthspan.

See also How does onychoschizia affect nail health?

In summary, rapamycin, as a caloric restriction mimetic, inhibits mTOR signaling by forming a complex with FKBP12, leading to the downregulation of mTORC1-dependent pathways. This inhibition promotes autophagy and affects cellular metabolism, ultimately contributing to the extension of lifespan and improvement of healthspan.

Keywords: rapamycin, cellular, signaling, caloric, restriction, lifespan, protein, autophagy, mimetic